These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3862124)

  • 41. New mono- and bis-intercalating compounds between DNA base pairs.
    Chiarelotto G; Ferlin MG; Vedaldi D; Dall'Acqua F; Rodighiero G
    Farmaco; 1993 Jun; 48(6):835-55. PubMed ID: 8373507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dark oxidation of unsaturated lipids and dihydroxy phenylalanine by photooxidized furocoumarins].
    Sukhorukov VL; Potanenko AIa; Zakharova VA
    Vopr Med Khim; 1983; 29(5):75-8. PubMed ID: 6417908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Local suppression of contact hypersensitivity in mice by a monofunctional psoralen plus UVA radiation.
    Alcalay J; Ullrich SE; Kripke ML
    Photochem Photobiol; 1989 Aug; 50(2):217-20. PubMed ID: 2780817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of psoralen and UVA (PUVA) on epidermal melanocytes of the tail in C57BL mice.
    Blog FB; Szabo G
    J Invest Dermatol; 1979 Dec; 73(6):533-7. PubMed ID: 512405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The application of antioxidants in investigations and optimization of photochemotherapy.
    Potapenko AY; Kyagova AA
    Membr Cell Biol; 1998; 12(2):269-78. PubMed ID: 9879549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption.
    Alalaiwe A; Hung CF; Leu YL; Tahara K; Chen HH; Hu KY; Fang JY
    Eur J Pharm Sci; 2018 Nov; 124():114-126. PubMed ID: 30153523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacokinetics of methoxsalen and other psoralens.
    de Wolff FA; Thomas TV
    Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-protein interaction: plasma protein binding of furocoumarins.
    Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
    Farmaco Sci; 1979 Aug; 34(8):716-25. PubMed ID: 467637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psoralen photofootprinting of protein-binding sites on DNA.
    Zhen WP; Jeppesen C; Nielsen PE
    FEBS Lett; 1988 Feb; 229(1):73-6. PubMed ID: 3345840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New furan side tetracyclic allopsoralen derivatives: synthesis and photobiological evaluation.
    Dalla Via L; Mammi S; Uriarte E; Santana L; Lampronti I; Gambari R; Gia O
    J Med Chem; 2006 Jul; 49(14):4317-26. PubMed ID: 16821791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Azapsoralens: new potential photochemotherapeutic agents for psoriasis.
    Vedaldi D; Caffieri S; Miolo G; Dall'Acqua F; Baccichetti F; Guiotto A; Benetollo F; Bombieri G; Recchia G; Cristofolini M
    Farmaco; 1991 Dec; 46(12):1407-33. PubMed ID: 1821628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative analysis of DNA interstrand cross-links and monoadducts formed in human cells induced by psoralens and UVA irradiation.
    Lai C; Cao H; Hearst JE; Corash L; Luo H; Wang Y
    Anal Chem; 2008 Nov; 80(22):8790-8. PubMed ID: 18947205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorescence studies on the interaction of furocoumarins with DNA in the dark.
    Gupta M; Ali R
    J Biochem; 1984 May; 95(5):1253-7. PubMed ID: 6746605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psoralen Derivatives with Enhanced Potency.
    Buhimschi AD; Gooden DM; Jing H; Fels DR; Hansen KS; Beyer WF; Dewhirst MW; Walder H; Gasparro FP
    Photochem Photobiol; 2020 Sep; 96(5):1014-1031. PubMed ID: 32221980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre-clinical evaluation of new antiproliferative agents for the photochemotherapy of psoriasis: angelicin derivatives.
    Bordin F; Baccichetti F; Carlassare F; Peron M; Dall'Acqua F; Vedaldi D; Guiotto A; Rodighiero P; Pathak MA
    Farmaco Sci; 1981 Jul; 36(7):506-18. PubMed ID: 7274437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phototherapy and photopharmacology.
    Gasparro FP; Chan G; Edelson RL
    Yale J Biol Med; 1985; 58(6):519-34. PubMed ID: 3832664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis.
    Bishop SC
    Br J Dermatol; 1979 Oct; 101(4):399-405. PubMed ID: 508605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The binding of 8-methoxypsoralen to nuclear DNA of UVA irradiated human fibroblasts in vitro.
    Bredberg A; Lambert B; Swanbeck G; Thyresson-Hök M
    Acta Derm Venereol; 1977; 57(5):389-91. PubMed ID: 73303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.